Cerus Corporation (CERS)
NASDAQ$1.45+0.06 (4.32%)
Market Cap
$258.25M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
325 of 924
Rank in Industry
41 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
CERS Insider Trading Activity
CERS Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $53,974 | 5 | 17 |
Sells | $1,279,172 | 24 | 83 |
Related Transactions
| Witney Frank | director | 1 | $37,800 | 0 | $0 | $37,800 |
| Shan Hua | director | 1 | $4,975 | 0 | $0 | $4,975 |
| Swisher Daniel N JR | director | 1 | $4,689 | 0 | $0 | $4,689 |
| NACHTSHEIM JAMI K | director | 1 | $3,578 | 0 | $0 | $3,578 |
| Gregory Dean A. | director | 1 | $2,933 | 0 | $0 | $2,933 |
| BJERKHOLT ERIC | director | 0 | $0 | 1 | $35,700 | $-35,700 |
| Moore Carol | SVP Reg. & Quality | 0 | $0 | 1 | $41,553 | $-41,553 |
| CORASH LAURENCE M | Chief Scientific Officer | 0 | $0 | 2 | $57,288 | $-57,288 |
| Jayaraman Vivek K | Chief Operating Officer | 0 | $0 | 4 | $174,515 | $-174,515 |
| Benjamin Richard J | Chief Medical Officer | 0 | $0 | 6 | $254,506 | $-254,506 |
| Jensen Chrystal | Chief Legal Officer | 0 | $0 | 6 | $280,041 | $-280,041 |
| Greenman William Mariner | President and CEO | 0 | $0 | 4 | $383,382 | $-383,382 |
| Green Kevin Dennis | Chief Financial Officer | 0 | $0 | 7 | $418,945 | $-418,945 |
About Cerus Corporation
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood …
Insider Activity of Cerus Corporation
Over the last 12 months, insiders at Cerus Corporation have bought $53,974 and sold $1.28M worth of Cerus Corporation stock.
On average, over the past 5 years, insiders at Cerus Corporation have bought $69,739 and sold $3.71M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Witney Frank (director) — $37,800. Shan Hua (director) — $4,975. Swisher Daniel N JR (director) — $4,689.
The last purchase of 1,725 shares for transaction amount of $2,933 was made by Gregory Dean A. (director) on 2024‑12‑13.
List of Insider Buy and Sell Transactions, Cerus Corporation
| 2025-03-07 | Sale | Greenman William Mariner | President and CEO | 60,984 0.0325% | $1.50 | $91,354 | -1.67% | |
| 2025-03-07 | Sale | Jayaraman Vivek K | Chief Operating Officer | 33,999 0.0181% | $1.50 | $50,931 | -1.67% | |
| 2025-03-07 | Sale | Green Kevin Dennis | Chief Financial Officer | 31,148 0.0166% | $1.50 | $46,660 | -1.67% | |
| 2025-03-07 | Sale | Jensen Chrystal | Chief Legal Officer | 27,457 0.0146% | $1.50 | $41,131 | -1.67% | |
| 2025-03-07 | Sale | Benjamin Richard J | Chief Medical Officer | 26,139 0.0139% | $1.50 | $39,156 | -1.67% | |
| 2025-03-04 | Sale | Greenman William Mariner | President and CEO | 23,023 0.0119% | $1.55 | $35,651 | -5.70% | |
| 2025-03-04 | Sale | Jayaraman Vivek K | Chief Operating Officer | 10,780 0.0056% | $1.55 | $16,693 | -5.70% | |
| 2025-03-04 | Sale | Green Kevin Dennis | Chief Financial Officer | 8,386 0.0043% | $1.55 | $12,986 | -5.70% | |
| 2025-03-04 | Sale | Jensen Chrystal | Chief Legal Officer | 66,292 0.035% | $1.58 | $104,885 | -5.70% | |
| 2025-03-04 | Sale | Benjamin Richard J | Chief Medical Officer | 6,292 0.0032% | $1.55 | $9,743 | -5.70% | |
| 2025-03-03 | Sale | Green Kevin Dennis | Chief Financial Officer | 60,656 0.0335% | $1.58 | $95,673 | -2.29% | |
| 2025-03-03 | Sale | Benjamin Richard J | Chief Medical Officer | 51,254 0.0283% | $1.58 | $80,828 | -2.29% | |
| 2024-12-16 | Sale | Jensen Chrystal | Chief Legal Officer | 16,667 0.0086% | $1.71 | $28,501 | -6.81% | |
| 2024-12-13 | Gregory Dean A. | director | 1,725 0.0009% | $1.70 | $2,933 | -1.75% | ||
| 2024-12-12 | Sale | BJERKHOLT ERIC | director | 20,000 0.0108% | $1.78 | $35,700 | -5.34% | |
| 2024-09-04 | Sale | Green Kevin Dennis | Chief Financial Officer | 54,272 0.0299% | $2.15 | $116,826 | -17.54% | |
| 2024-09-03 | Sale | Green Kevin Dennis | Chief Financial Officer | 28,385 0.0153% | $2.18 | $61,919 | -20.55% | |
| 2024-08-15 | Sale | Jensen Chrystal | Chief Legal Officer | 16,667 0.0092% | $2.06 | $34,417 | -18.72% | |
| 2024-08-02 | Sale | Benjamin Richard J | Chief Medical Officer | 21,605 0.0125% | $2.50 | $54,013 | -24.26% | |
| 2024-05-13 | Shan Hua | director | 2,500 0.0013% | $1.99 | $4,975 | -10.00% |
Total: 228
*Gray background shows transactions not older than one year
Insider Historical Profitability
22.18%
| Greenman William Mariner | President and CEO | 4309758 2.3197% | $5.99M | 5 | 14 | +31.07% |
| CORASH LAURENCE M | Chief Scientific Officer | 2339740 1.2593% | $3.25M | 37 | 8 | +15.15% |
| Witney Frank | director | 180059 0.0969% | $250,282.01 | 2 | 0 | +47.63% |
| BJERKHOLT ERIC | director | 162133 0.0873% | $225,364.87 | 4 | 1 | +13.43% |
| NACHTSHEIM JAMI K | director | 108362 0.0583% | $150,623.18 | 2 | 0 | +47.63% |
*Gray background shows insiders who have made transactions during last year
CERS Institutional Investors: Active Positions
| Increased Positions | 80 | +61.54% | 12M | +8.07% |
| Decreased Positions | 46 | -35.38% | 13M | -8.87% |
| New Positions | 19 | New | 940,093 | New |
| Sold Out Positions | 15 | Sold Out | 723,170 | Sold Out |
| Total Postitions | 164 | +26.15% | 148M | -0.8% |
CERS Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Ark Investment Management Llc | $34,344.00 | 11.19% | 20.81M | +3M | +14.21% | 2024-12-31 |
| Baker Bros. Advisors Lp | $32,138.00 | 10.47% | 19.48M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $24,452.00 | 7.97% | 14.82M | +150,408 | +1.02% | 2024-12-31 |
| Vanguard Group Inc | $17,186.00 | 5.6% | 10.42M | -432,060 | -3.98% | 2024-12-31 |
| Wasatch Advisors Lp | $13,728.00 | 4.47% | 8.32M | +994,007 | +13.57% | 2024-12-31 |
| Sumitomo Mitsui Trust Group, Inc. | $10,662.00 | 3.47% | 6.46M | -578,603 | -8.22% | 2024-12-31 |
| Nikko Asset Management Americas, Inc. | $10,662.00 | 3.47% | 6.46M | -578,603 | -8.22% | 2024-12-31 |
| Senvest Management, Llc | $10,550.00 | 3.44% | 6.39M | +387,603 | +6.45% | 2024-12-31 |
| Geode Capital Management, Llc | $7,350.00 | 2.4% | 4.45M | +39,072 | +0.89% | 2024-12-31 |
| State Street Corp | $6,278.00 | 2.05% | 3.8M | +65,723 | +1.76% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.